Therapeutic Innovation Australia is a national consortium of translational research infrastructure. 
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
​
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.

29 April 2021​

 

 

 

TIA announces investment in Protein Expression Facility (PEF), the nucleic acids facility at AIBN, UQ

​

TIA is excited to announce the investment in PEF to support the development of nucleic acids (RNA and DNA) for research and development.

TIA-Logo_Dark-Blue_TRANS.png
Press release